North China Pharmaceutical Company.Ltd
North China Pharmaceutical Company Ltd. (NCPC), headquartered in China, is a leading player in the pharmaceutical industry, renowned for its extensive range of high-quality products and services. Established in 1999, NCPC has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms, and biopharmaceuticals, catering to both domestic and international markets. With a strong operational presence across various regions in China, NCPC has positioned itself as a key supplier in the healthcare sector. The company is distinguished by its commitment to innovation and quality, offering unique formulations that meet stringent regulatory standards. Notable achievements include its robust portfolio of over 200 products and a reputation for excellence in research and development, solidifying its status as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does North China Pharmaceutical Company.Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
North China Pharmaceutical Company.Ltd's score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
North China Pharmaceutical Company.Ltd's reported carbon emissions
North China Pharmaceutical Company Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, North China Pharmaceutical Company Ltd does not inherit emissions data from any parent or related organizations, indicating that its climate commitments and performance metrics are independently assessed. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate initiatives. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from North China Pharmaceutical Company Ltd, it remains unclear how they align with these industry trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
North China Pharmaceutical Company.Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
